Quinton floats to raise $32 million:
This article was originally published in Clinica
Executive Summary
The underwriters of Quinton Cardiology Systems' IPO have exercised their over-allotment option to buy a further 600,000 shares, bringing the total gross proceeds to $32.2m. The Bothell, Washington company is a provider of cardiac stress testing systems, cardiac rehabilitation equipment, Holter monitoring devices and haemodynamic monitoring solutions.